New asthma inhaler for teens shows promise in early trial

NCT ID NCT07065331

Completed Symptom relief Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 25 times

Summary

This study tested a single dose of an inhaled drug called AZD8630 in 10 teenagers with asthma. The goal was to see how the drug moves through the body and whether it is safe. Participants used a dry powder inhaler and were monitored for side effects and immune responses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Bakersfield, California, 93301, United States
Research Site

Miami Lakes, Florida, 33014, United States
Research Site

Lafayette, Louisiana, 70508, United States
Research Site

Raleigh, North Carolina, 27607, United States
Research Site

Toledo, Ohio, 43617, United States
Research Site

Oklahoma City, Oklahoma, 73120, United States
Research Site

Spartanburg, South Carolina, 29303, United States
Research Site

Boerne, Texas, 78006, United States
Research Site

Salt Lake City, Utah, 84107, United States

Conditions

Explore the condition pages connected to this study.

ASTHMA